MétaCan
Menu
Back to cohort
Record W4414792538 · doi:10.1093/neuonc/noaf193.423

P12.44.A ADJUVANT CHEMORADIOTHERAPY WITH PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV) OR TEMOZOLOMIDE FOR 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA: A NETWORK META-ANALYSIS

2025· article· en· W4414792538 on OpenAlexaff
Marisa D. Santos, Natasha Maranhão Vieira Rodrigues, Franceliny Gibram, Felipe Araújo Gouhie, Armando Campos, Ângelo Nobre, Olavo Feher, Samir Abdallah Hanna, Caroline Chung, Cássia Maria Passarelli Lupoli Barbosa, Fábio Ynoe de Moraes, Marcos Vinícius Calfat Maldaun

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsQueen's University
Fundersnot available
KeywordsTemozolomideVincristineAnaplastic astrocytomaHazard ratioDacarbazineRadiation therapyOligodendrogliomaProgression-free survivalLomustine

Abstract

fetched live from OpenAlex

Abstract BACKGROUND Anaplastic oligodendrogliomas (IDH-mutant and 1p/19q-codeleted) are rare diffuse gliomas characterized by favorable responses to chemoradiotherapy. Although radiotherapy (RT) combined with procarbazine, lomustine, and vincristine (PCV) has been the historical standard, temozolomide (TMZ) has been increasingly used due to its more favorable toxicity profile. However, direct comparisons between these regimens are limited. To compare the efficacy of RT combined with PCV versus RT combined with TMZ in adult patients with anaplastic oligodendroglioma characterized by confirmed 1p/19q co-deletion by conducting a network meta-analysis (NMA). MATERIAL AND METHODS A systematic search of PubMed, Embase, and the Cochrane Library was conducted up to March 2025. Eligible studies included patients with 1p/19q-codeleted anaplastic oligodendroglioma treated with RT+PCV, RT+TMZ, or RT alone. Both randomized trials, prospective, and retrospective cohorts were included. Studies comparing RT alone to RT+PCV or RT+TMZ were used to create indirect comparisons, with RT as a common comparator. A frequentist network meta-analysis with a random-effects model estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for overall survival (OS) and progression-free survival (PFS). Consistency and heterogeneity were assessed using standard statistical methods. RESULTS Eight studies comprising 2,416 patients were included. In the network meta-analysis, compared with RT alone, RT+PCV significantly improved OS (HR: 0.617; 95% CI 0.465- 0.819; p = 0.0009), and PFS (HR: 0.547; 95% CI 0.415- 0.721; p < 0.0001), while RT+TMZ showed a trend toward improved OS (HR: 0.913; 95% CI 0.666- 1.252; p = 0.421) and PFS (HR: 1.270; 95% CI 0.870- 1.855; p = 0.215), without statistical significance. These comparisons with RT alone were included to establish the network structure. The primary objective of the study was the direct and indirect comparison between RT+PCV and RT+TMZ, in which RT+PCV demonstrated superior OS (HR: 0.676; 95% CI, 0.585-0.781; p < 0.0001) and better PFS (HR: 0.431; 95% CI, 0.325-0.570; p < 0.0001). Network consistency was confirmed (p > 0.1), (Q_between = 0.44; p = 0.506) to OS and (Q_between = 0.02; p = 0.8818) to PFS. CONCLUSION In patients with 1p/19q-codeleted anaplastic oligodendroglioma, RT combined with PCV provides superior survival outcomes compared to radiotherapy combined with TMZ. These findings support the continued use of PCV as the preferred chemoradiotherapy regimen when feasible, while emphasizing the need for future randomized trials to validate these results.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.012
Threshold uncertainty score0.034

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.011
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0120.044
Bibliometrics0.0040.005
Science and technology studies0.0000.000
Scholarly communication0.0020.002
Open science0.0020.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.042
GPT teacher head0.340
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207